For further details, please refer to the ‘Product Introduction’ section and attached documents.
Olodipine tablets 5/20, 5/40, 10/40 milligrams
In accordance with the 'Drug Approval Change Order' (Drug Safety Evaluation Division-No. 673, effective date July 15, 2015), the precautions for the use of Olodipine Tablets have been changed.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Permit_Change Instruction_and_Change Comparison Table Olmesartan Medoxomil,Permission_Change Instruction_and_Change Comparison Table Olmesartan Medoxomil,.hwp · 43 KBDownload ↓